JJ Singleton was a 27-year-old athlete from the small Appalachian town in North Carolina, when he was diagnosed with aggressive colorectal cancer. His story highlights the alarming rise of early-onset colorectal cancer, a disease now the leading cause of cancer death for men under 50.

Growing up in a rural community where going to the doctor was often avoided and early death was dismissed as “God’s will,” JJ wasn’t diagnosed with colon cancer until a visible tumor throbbed in his abdomen. His journey from brutal chemotherapy failures to a life-stabilizing immunotherapy clinical trial at Duke is a powerful testament to the promise of precision medicine—turning terminal cancer into a manageable chronic condition.

Yet, his story also exposes a critical cancer care disparity: the immense difficulty rural patients face in accessing the very trials that could save them. This episode explores how geography, limited resources, and a lack of knowledge about accessing healthcare as a preventative strategy creates an intimidating barrier between rural Americans and cutting-edge care.

Key Takeaways:

• Early-Onset Crisis: Colorectal cancer is rising dramatically in adults under 50 and is now a leading cause of cancer death in this age group.
• Rural Disparity: Where you live is a major social determinant of health, creating significant barriers to screening, specialist care, and life-saving clinical trials.
• Chronic Disease Potential: Immunotherapy and precision medicine trials are beginning to successfully turn some advanced, active cancers into controllable chronic conditions.

We amplify Colorectal Cancer Awareness Month with JJ’s personal advocacy to a national conversation on prevention, breaking stigma, and the systemic changes needed to bridge the gap to precision medicine for every patient, regardless of their zip code.

Follow JJ Singleton XFacebookInstagram

META DESCRIPTION

This podcast episode shares the incredible journey of JJ Singleton from rural Appalachia diagnosed with aggressive colon cancer at age 27. After struggling through harsh chemotherapy, he found new hope through an immunotherapy clinical trial using Keytruda (pembrolizumab), which has successfully stabilized his cancer and allowed him to live a full, active life for years—showing how modern treatments can turn cancer into a manageable chronic condition. We also tackle the alarming rise of early-onset colorectal cancer in younger adults, and the vital importance of cancer screening and breaking stigma around symptoms. Learn the language of precision medicine and build the confidence to talk to your doctor and family, and become an effective self-advocate for a precision medicine approach to your healthcare.